Should trials of liver xenotransplantation proceed in toxic fulminant hepatic failure? [3]

Xenotransplantation

Volumn 13, Issue 6, 2006, Pages 483-

  Horton, Peter J ^a   Chaudhury, Prosanto ^a   Rochon, Caroline ^a   Metrakos, Peter ^a   Tchervenkov, Jean ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; GRAFT SURVIVAL; HUMAN; LETTER; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RETRANSPLANTATION; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; RISK FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33750064235     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2006.00337.x     Document Type: Letter

References (6)

1. GUBERNATIS G, PICHLMAYR R, KEMNITZ J, GRATIZ K. Auxillary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 1991; 15: 660.
2. LODGE JPA, PRASAD KR, TOOGOOD GJ et al. Auxillary orthotopic liver transplantation: new technique and results in toxic liver injury. Transplant Proc 2001; 33: 1403.
3. STARZL TE, FUNG J, TZAKIS A et al. Baboon-to-human liver transplant. Lancet 1993; 341: 65.
4. MAKOWKA L, CRAMER DV, HOMAN A, SHER L, PODESTA L. Pig liver xenografts as a temporary bridge for human allografting. Xenotransplantation 1993; 1: 27.
5. COZZI E, WHITE D. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
6. MCCURRY K, KOOYMAN D, ALVARADO C. Human complement regulatory proteins protect swine-to-primate cardic xenografts from humeral injury. Nat Med 1995; 1: 423.